2017 PCR-CIT China Chengdu Valves
2017-11-24 13:00:00~2017-11-26 13:00:00
Webcast Introduction
Under the sponsor of China Center of International Science and Technology Exchange（CISTE）and joint-organization of PCR, CIT (China Interventional Therapeutics), and West China Hospital of Sichuan University, the 3rd edition of “PCR-CIT China Chengdu Valves” (PCCV) is scheduled from 23th-26th November, 2017 in Chengdu, China. It will be organized based on the successful experience of PCR London Valves, under the theme of Transcatheter Aortic Valve Implantation (TAVI). This conference will focus on basic skill training through hands-on practice, live demonstration, academic lectures and case-based discussions. The PCCV course will help improve the ability of doctors in China and the Asia-Pacific region to use this technology and hopefully promote its development for the benefits of the patients.
Program
教育性TAVI病例专场-1
17:00-18:10 Branch Venue
Chairpersons: 冯沅 周达新
Panelists: 孔祥清 刘先宝 潘文志 宋光远 张戈军
Time
Content
Speaker
7Minutes
病例1（轻中度瓣叶钙化的三叶式主动脉瓣狭窄）
Case 1 (TAVI for tricuspid aortic valve stenosis with mild-moderate leaflet calcification)
韩克
Ke HAN
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例2（重度瓣叶钙化的三叶式主动脉瓣狭窄）
Case 2 (TAVI for tricuspid aortic valve stenosis with severe leaflet calcification)
1
马翔
Xiang MA
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例3（轻中度瓣叶钙化的二叶式主动脉瓣狭窄）
Case 3 (TAVI for bicuspid aortic valve stenosis with mild-moderate leaflet calcification)
潘文志
Wen-Zhi PAN
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例4（重度瓣叶钙化的二叶式主动脉瓣狭窄）
Case 4 (TAVI for bicuspid aortic valve stenosis with severe leaflet calcification)
宋光远
Guang-Yuan SONG
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例5（无钙化主动脉瓣狭窄）
Case 5 (TAVI for non-calcific aortic valve stenosis)
刘先宝
Xian-Bao LIU
5Minutes
讨论：React@PCCV
Discussion React@PCCV
10Minutes
关键信息：不同解剖形态中TAVI的推荐策略
Take home message: Suggested maneuvers during TAVI procedure for different morphologies
Nicolo PIAZZA
Nicolo PIAZZA
经导管瓣膜介入治疗：未来5年我们该期待什么？
10:00-12:00 Branch Venue
Chairpersons: Bernard PRENDERGAST William WIJNS
Panelists: 陈茂 孔祥清 Thomas MODINE Nicolo PIAZZA Atiq REHMAN 殷伟贤
Time
Content
Speaker
3Minutes
欢迎辞
Welcoming address
Bernard PRENDERGAST
Run-Lin GAO
5Minutes
PCRCCV创新论坛介绍
Introduction of PCRCCV Innovation Forum
陈茂
Mao CHEN
主题1：经导管主动脉瓣置入术
Theme 1: Transcatheter aortic valve implantation
主持: Bernard PRENDERGAST, William WIJNS
Facilitators: Bernard PRENDERGAST, William WIJNS
讨论专家: 陈茂, 孔祥清, Thomas MODINE, Nicolo PIAZZA, Atiq REHMAN, 殷伟贤
Panellists: Mao CHEN, Xiang-Qing KONG, Thomas MODINE, Nicolo PIAZZA, Atiq REHMAN, Wei-Hsian YIN
8Minutes
概述：现状及尚未满足的需求
Overview of the field: Where are we now? What are the unmet need?
Bernard PRENDERGAST
Bernard PRENDERGAST
8Minutes
满足需求：来自启明医疗的创新性方案
Addressing the unmet needs: innovative solutions from Venus MedTech
2
訾振军
Eric ZI
8Minutes
满足需求：来自微创医疗的创新性方案
Addressing the unmet needs: innovative solutions from MicroPort
2
陈国明
Guo-Ming CHEN
8Minutes
转化医学：生物材料科学的未来
Transformational technologies on the horizon: what does biomaterial science promise?
2
王云兵
Yun-Bing WANG
20Minutes
讨论及互动
Discussion and audience interaction
11Minutes
休息
Coffee and Tea break
主题2：经皮二尖瓣及三尖瓣介入治疗
Theme 2: Percutaneous mitral and tricuspid valve interventions
主持: Bernard PRENDERGAST, William WIJNS
Facilitators: Bernard PRENDERGAST, William WIJNS
讨论专家: 陈茂, 孔祥清, Thomas MODINE, Nicolo PIAZZA, Atiq REHMAN, 殷伟贤
Panellists: Mao CHEN, Xiang-Qing KONG, Thomas MODINE, Nicolo PIAZZA, Atiq REHMAN, Wei-Hsian YIN
8Minutes
经皮二尖瓣及三尖瓣介入治疗：现状、挑战及展望
Percutaneous mitral and tricuspid valve intervention: current status, challenges and future perspectives
3
Nicolo PIAZZA
Nicolo PIAZZA
8Minutes
外科治疗二尖瓣及三尖瓣反流：对创新性经皮介入治疗的启示
Surgical approaches to mitral and tricuspid regurgitation: implications for innovations in percutaneous intervention
4
Atiq REHMAN
Atiq REHMAN
8Minutes
二尖瓣“瓣中瓣”及“环中瓣”手术
Mitral valve-in-valve and valve-in-ring
2
Thomas MODINE
Thomas MODINE
20Minutes
讨论及互动
Discussion and audience interaction
总结
Concluding remarks
主持: Bernard PRENDERGAST, William WIJNS
Facilitators: Bernard PRENDERGAST, William WIJNS
讨论专家: 陈茂, 孔祥清, Thomas MODINE, Nicolo PIAZZA, Atiq REHMAN, 殷伟贤
Panellists: Mao CHEN, Xiang-Qing KONG, Thomas MODINE, Nicolo PIAZZA, Atiq REHMAN, Wei-Hsian YIN
5Minutes
总结
Concluding remarks
William WIJNS
William WIJNS
心脏团队圆桌讨论: 何为患者的最佳治疗选择？
13:00-14:00 Main Arena
学习目标:
>了解2017年TAVI适应人群
>熟悉TAVI患者选择的地区差异及其影响因素（如预期寿命）
>学习评估TAVI指征所需信息
Chairpersons: 陈茂 Thomas MODINE
Panelists: Praveen CHANDRA 陈果 冯沅 蒙炜 Atiq REHMAN 殷伟贤
Speaker: 冯沅
Time
Content
Speaker
5Minutes
学习目标介绍
Session objectives
陈茂
Mao CHEN
45Minutes
病例介绍及圆桌讨论：React@PCCV
Case presentation & roundtable discussion & audience interaction after each part of the history React@PCCV
冯沅
Yuan FENG
5Minutes
现场测验和答疑
Knowledge assessment (multiple choice questions) and interpretation
5Minutes
总结
Session evaluation and key learnings
Thomas MODINE
Thomas MODINE
30Minutes- 14:00-14:30
休息
Coffee and Tea break
TAVI影像专场 第一部分：超声
14:30-15:10 Main Arena
学习目标:
>了解有时诊断主动脉瓣狭窄存在困难的原因
>学习低流速低跨瓣压差主动脉瓣狭窄的超声评估要点
>了解超声在TAVI术前准备中的重要性
Chairpersons: Nicolo PIAZZA 唐红
Panelists: 潘翠珍 Lars SØNDERGAARD 殷伟贤 周达新
Time
Content
Speaker
5Minutes
病例介绍1(射血分数下降的低流速低跨瓣压差主动脉瓣狭窄)
Case 1 presentation (low-flow low-gradient aortic stenosis with reduced ejection fraction)
3
潘翠珍
Cui-Zhen PAN
7Minutes
讨论：React@PCCV
Panel discussion & interaction with audiences React@PCCV
5Minutes
病例解决方案
Case resolution
潘翠珍
Cui-Zhen PAN
5Minutes
病例介绍2(射血分数保留的低流速低跨瓣压差主动脉瓣狭窄)
Case 2 presentation (low-flow low-gradient aortic stenosis with preserved ejection fraction)
3
魏薪
Xin WEI
7Minutes
讨论：React@PCCV
Panel discussion & interaction with audiences React@PCCV
5Minutes
病例解决方案
Case resolution
魏薪
Xin WEI
6Minutes
现场测验和答疑
Knowledge assessment (multiple choice questions) and interpretation
TAVI影像专场 第二部分：CT
15:10-16:40 Main Arena
学习目标:
>掌握与TAVI密切相关的重要解剖结构
>学习分步分析TAVI术前CT图像
>学习如何将CT评估融入手术计划
Chairpersons: Kentaro HAYASHIDA Darren MYLOTTE
Time
Content
Speaker
15Minutes
应该评估哪些解剖结构？为什么？
Which anatomies should be analysed? why?
6
Nicolo PIAZZA
Nicolo PIAZZA
15Minutes
讨论：React@PCCV
Discussion React@PCCV
40Minutes
现场分步演示TAVI术前CT影像分析
LIVE CT analysis step by step
Nicolo PIAZZA
Nicolo PIAZZA
20Minutes
讨论：React@PCCV
Discussion React@PCCV
20Minutes - 16:40-17:00
休息
Coffee and Tea break
并发症论坛：如何利用影像避免并发症
17:00-18:00 Main Arena
学习目标:
>了解影像学对于TAVI成功的重要性
>学习如何通过完善的术前影像评估预测并避免TAVI并发症
>分享为达到结果最优化所使用的影像技术及手术策略
Chairpersons: Bernard PRENDERGAST Lars SØNDERGAARD
Time
Content
Speaker
病例1
Case 1
5Minutes
病例介绍
Case presentation
殷伟贤
Wei-Hsian YIN
10Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
病例解决方案及关键信息
Case resolution and take-home message
殷伟贤
Wei-Hsian YIN
病例2
Case 2
5Minutes
病例介绍
Case presentation
Kentaro HAYASHIDA
Kentaro HAYASHIDA
10Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
病例解决方案及关键信息
Case resolution and take-home message
Kentaro HAYASHIDA
Kentaro HAYASHIDA
病例3
Case 3
5Minutes
病例介绍
Case presentation
陆毅康
Vincent LUK
10Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
病例解决方案及关键信息
Case resolution and take-home message
陆毅康
Vincent LUK
学习TAVI的分步操作
08:00-09:30 Main Arena
学习目标:
>学习标准TAVI操作关键步骤及其细节
>了解已经或即将在中国上市的TAVI瓣膜的植入技巧
>分享潜在并发症的预防与处置策略
Chairpersons: 陈茂 Thomas MODINE Lars SØNDERGAARD
Experts: Praveen CHANDRA Kentaro HAYASHIDA 罗建方 Atiq REHMAN 王建安 王焱 杨跃进 殷伟贤 Cheol Woong Yu
Media driver: 赵振刚
Time
Content
Speaker
20Minutes - 08:00-09:30
学习TAVI的分步操作
10
15Minutes - 09:50-10:05
PCR London Valves@PCR-CIT China Chengdu Valves
PCR London Valves@PCR-CIT China Chengdu Valves
3Minutes
PCR London Valves 2017闭幕视频
Closing video of PCR London Valves 2017
12Minutes
PCR London Valves 2017学术精要
Highlights of PCR London Valves 2017
Bernard PRENDERGAST
Bernard PRENDERGAST
开幕式
10:10-10:30 Main Arena
TAVI示教演示
10:30-12:10 Main Arena
学习目标:
>学习通过CT评估结果指导制定手术策略
>学习如何完成一次完整而标准的TAVI操作
>探讨达到患者结果最优化的要点与技巧
Chairpersons: 陈茂 Thomas MODINE Lars SØNDERGAARD
Experts: Praveen CHANDRA Kentaro HAYASHIDA 罗建方 Atiq REHMAN 王建安 王焱 杨跃进 殷伟贤 Cheol Woong Yu
Operators: Darren MYLOTTE 冯沅 方臻飞
Time
Content
Speaker
5Minutes
病例介绍
Case presentation
Darren MYLOTTE
Darren MYLOTTE
3Minutes
器械介绍
Tool presentation
陈茂
Mao CHEN
7Minutes
现场CT评估及手术策略讨论
LIVE CT analysis for strategic plans
Nicolo PIAZZA
Nicolo PIAZZA
5Minutes
讨论：React@PCCV
Discussion React@PCCV
70Minutes
TAVI直播
LIVE Demo of TAVI skin to skin
10Minutes
讨论：React@PCCV
Discussion React@PCCV
30Minutes - 12:10-12:40
午休
Lunch
瓣膜专场
12:40-13:40 Main Arena
学习目标:
>了解已经或即将在中国上市的TAVI瓣膜的设计特点
>熟悉各类TAVI瓣膜的优势
>讨论不同解剖特征的患者的TAVI瓣膜选择策略
Chairpersons: 徐波 周玉杰
Panelists: 陈韵岱 孔祥清 Nicolo PIAZZA Edgar TAY
Time
Content
Speaker
8Minutes
Edwards Sapien 3: 设计特点及典型病例
Edwards Sapien 3: technology overview and case example
1
Kentaro HAYASHIDA
Kentaro HAYASHIDA
4Minutes
讨论：React@PCCV
Discussion React@PCCV
8Minutes
Boston Scientific Lotus: 设计特点及典型病例
Boston Scientific Lotus: technology overview and case example
Nicolo PIAZZA
Nicolo PIAZZA
4Minutes
讨论：React@PCCV
Discussion React@PCCV
8Minutes
MicroPort VitaFlow: 设计特点及典型病例
MicroPort VitaFlow: technology overview and case example
1
Darren MYLOTTE
Darren MYLOTTE
4Minutes
讨论：React@PCCV
Discussion React@PCCV
8Minutes
Venus A-Valve: 设计特点及典型病例
Venus A-Valve: technology overview and case example
宋光远
Yue-Jin YANG
4Minutes
讨论：React@PCCV
Discussion React@PCCV
6Minutes
Venus MedTech TAVI培训项目简介
A brief introduction to Venus MedTech TAVI training programme
杨军生
Jun-Sheng YANG
3Minutes
总结
Session evaluation and key learnings
周玉杰
Yu-Jie Zhou
焦点辩论
13:40-14:40 Main Arena
学习目标:
>讨论2017年中国哪些患者应接受TAVI或外科换瓣
>学习何时及如何简化TAVI流程
>了解TAVI应用现状及发展趋势
Chairpersons: Bernard PRENDERGAST
Moderator: Thomas MODINE
Time
Content
Speaker
主题1: 2017年中国中危患者是否适合接受TAVI？
Topic 1: Are intermediate-risk patients appropriate for China in 2017?
5Minutes
正方陈述
Presentation of pros
刘先宝
Jian-An WANG
5Minutes
反方陈述
Presentation of cons
陈茂
Mao CHEN
15Minutes
辩论环节：Thomas MODINE进程控制
Moderated debate
Moderated by Thomas MODINE
5Minutes
总结：您需要记住的关键信息
What I will remember
Bernard PRENDERGAST
Bernard PRENDERGAST
主题2: 目前在中国是否应该简化TAVI流程?
Topic 2: Should we simplify TAVI in China now?
5Minutes
正方陈述
Presentation of pros
Darren MYLOTTE
Darren MYLOTTE
5Minutes
反方陈述
Presentation of cons
1
宋光远
Yue-Jin YANG
15Minutes
辩论环节：Thomas MODINE进程控制
Moderated debate
Moderated by Thomas MODINE
5Minutes
总结：您需要记住的关键信息
What I will remember
Bernard PRENDERGAST
Bernard PRENDERGAST
20Minutes - 14:40-15:00
休息
Coffee and Tea break
二瓣化主动脉瓣狭窄的TAVI治疗
15:00-16:40 Main Arena
学习目标:
>熟悉TAVI治疗二瓣化主动脉瓣狭窄的现状及挑战
>学习二瓣化主动脉瓣狭窄患者的最佳影像检查手段及特殊植入技巧
>分享避免手术失败及降低并发症风险的策略和技巧
Chairpersons: 林逸贤 Nicolo PIAZZA
Panelists: Praveen CHANDRA 罗建方 刘长福 Thomas MODINE Atiq REHMAN 王建安
Operators: 陈茂 冯沅 Lars SØNDERGAARD
Time
Content
Speaker
全体会议
Plenary session
15Minutes
TAVI在二瓣化主动脉瓣狭窄中的应用前景、技术挑战及针对性策略
Rationale, challenges and pertinent strategies for TAVI in bicuspid aortic valve
Nicolo PIAZZA
Nicolo PIAZZA
15Minutes
讨论：React@PCCV
Discussion React@PCCV
TAVI直播
Supportive LIVE Demo
5Minutes
病例介绍
Case presentation
陈茂
Mao CHEN
3Minutes
器械介绍
Tool presentation
Thomas MODINE
Thomas MODINE
7Minutes
现场CT评估及手术策略讨论
LIVE CT analysis for strategic plans
Darren MYLOTTE
Darren MYLOTTE
5Minutes
讨论：React@PCCV
Discussion React@PCCV
40Minutes
TAVI直播
LIVE Demo
10Minutes
讨论：React@PCCV
Discussion React@PCCV
20Minutes - 16:40-17:00
休息
Coffee and Tea break
并发症论坛：我应该如何治疗？
17:00-18:00 Main Arena
学习目标:
>学习如何及时发现TAVI并发症
>学习如何有效处理各类TAVI并发症
>探讨降低TAVI术后并发症风险的要点与技巧
Chairpersons: 霍勇 Lars SØNDERGAARD
Panelists: 陈韵岱 Kentaro HAYASHIDA 黄岚 林茂新 Bernard PRENDERGAST 陶凌 周玉杰
Time
Content
Speaker
并发症病例1
Complication case 1
5Minutes
病例介绍
Case presentation
陈良贵
Jason CHAN
15Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
我是如何治疗的？
How did I treat?
陈良贵
Jason CHAN
5Minutes
总结
Case learnings
霍勇
Yong HUO
并发症病例2
Complication case 2
5Minutes
病例介绍
Case presentation
Edgar TAY
Edgar TAY
15Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
我是如何治疗的？
How did I treat?
Edgar TAY
Edgar TAY
5Minutes
总结
Case learnings
Lars SØNDERGAARD
Lars SØNDERGAARD
互动TAVI病例专场-1
12:40-13:40 Branch Venue
Chairpersons: 何奔 林逸贤
Panelists: 林茂新 刘先宝 徐标
Time
Content
Speaker
7Minutes
病例1
Case 1
康慧元
Huiyuan KANG
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例2
Case 2
刘巍
Wei LIU
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例3
Case 3
李飞
Fei LI
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例4
Case 4
3
朱达
Da ZHU
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例5
Case 5
彭勇
Yong PENG
5Minutes
讨论：React@PCCV
Discussion React@PCCV
互动TAVI病例专场-2
17:00-18:00 Branch Venue
Chairpersons: 罗建方 王焱
Panelists: 方臻飞 陆毅康 马翔 宋光远
Time
Content
Speaker
7Minutes
病例1
Case 1
朱政斌
Zheng-Bin ZHU
5Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例3
Case 3
蒋博
Bo JIANG
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例4
Case 4
徐凯
Kai XU
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例5
Case 5
廖延标
Yan-Biao LIAO
5Minutes
讨论：React@PCCV
Discussion React@PCCV
TAVI面临的挑战：我应该如何治疗？
08:30-09:30 Main Arena
学习目标:
>了解当经股动脉入路不可行时可选的替代入路及各自劣势
>讨论瓣膜血栓的预测因子及临床相关性
>学习在面临挑战时如何选择适合的评估方法并做出正确的治疗决策
Chairpersons: 陈茂 Bernard PRENDERGAST
Panelists: Praveen CHANDRA Atiq REHMAN Edgar TAY 王建安 徐亚伟 杨跃进
Time
Content
Speaker
病例1: 困难血管入路
Case 1: difficult vascular access
5Minutes
病例介绍
Case presentation
Thomas MODINE
Thomas MODINE
15Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
我是如何治疗的？
How did I treat?
Thomas MODINE
Thomas MODINE
5Minutes
总结
Case learnings
Bernard PRENDERGAST
Bernard PRENDERGAST
病例2: 瓣膜血栓
Case 2: valve thrombosis
5Minutes
病例介绍
Case presentation
Lars SØNDERGAARD
Lars SØNDERGAARD
15Minutes
讨论：React@PCCV
Discussion React@PCCV
5Minutes
我是如何治疗的？
How did I treat?
Lars SØNDERGAARD
Lars SØNDERGAARD
5Minutes
总结
Case learnings
陈茂
Mao CHEN
PCR-CIT China Chengdu Valves及PCR Tokyo Valves联合论坛: 亚太地区TAVI现状及未来
09:35-10:40 Main Arena
学习目标:
>了解亚太地区不同国家TAVI的现状及经验
>认识亚太地区主动脉瓣狭窄经皮介入治疗所面临的挑战
>与国际同行交流TAVI心得
Chairpersons: 陈茂 William WIJNS
Panelists: Kentaro HAYASHIDA 林逸贤 Darren MYLOTTE 吴永健 徐波
Time
Content
Speaker
2Minutes
学习目标介绍
Session objectives
陈茂
Mao CHEN
7Minutes
中国TAVI的现状、挑战及经验
Current status, challenges and experiences of TAVI in China
2
陈茂
Mao CHEN
3Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
日本TAVI的现状、挑战及经验
Current status, challenges and experiences of TAVI in Japan
Kentaro HAYASHIDA
Kentaro HAYASHIDA
3Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
韩国TAVI的现状、挑战及经验
Current status, challenges and experiences of TAVI in Korea
Cheol Woong Yu
Cheol Woong Yu
3Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
印度TAVI的现状、挑战及经验
Current status, challenges and experiences of TAVI in India
Praveen CHANDRA
Praveen CHANDRA
3Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
新加坡TAVI的现状、挑战及经验
Current status, challenges and experiences of TAVI in Singapore
1
Paul CHIAM
Paul CHIAM
3Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
美国TAVI的现状、挑战及经验
Current status, challenges and experiences of TAVI in US
Atiq REHMAN
Atiq REHMAN
3Minutes
讨论：React@PCCV
Discussion React@PCCV
3Minutes
总结
Session evaluation and key learnings
William WIJNS
William WIJNS
20Minutes - 10:40-11:00
休息
Coffee and Tea break
TAVI在外科生物瓣退化中的应用
11:00-12:40 Main Arena
学习目标:
>了解TAVI在外科生物瓣退化中的应用现状、挑战及缺陷
>学习“瓣中瓣”TAVI的最佳影像评估手段及特殊植入技术
>探讨避免并发症及优化治疗效果的要点与技巧
Chairpersons: Nicolo PIAZZA 徐波
Panelists: 陈茂 Paul CHIAM 李耿渊 Thomas MODINE Atiq REHMAN 吴永健
Operators: 台湾振兴医院TAVI团队（魏峥、殷伟贤）
Time
Content
Speaker
全体会议
Plenary session
15Minutes
TAVI在外科生物瓣退化中的应用前景、技术挑战及针对性策略
Rationale, challenges and pertinent strategies for TAVI in failed surgical bioprosthesis
Bernard PRENDERGAST
Bernard PRENDERGAST
15Minutes
讨论：React@PCCV
Discussion React@PCCV
TAVI直播
Supportive LIVE Demo
5Minutes
病例介绍
Case presentation
殷伟贤
Wei-Hsian YIN
3Minutes
器械介绍
Tool presentation
陈茂
Mao CHEN
7Minutes
现场CT评估及手术策略讨论
LIVE CT analysis for strategic plans
Darren MYLOTTE
Darren MYLOTTE
5Minutes
讨论：React@PCCV
Discussion React@PCCV
40Minutes
TAVI直播
LIVE Demo
10Minutes
讨论：React@PCCV
Discussion React@PCCV
闭幕式
12:45-13:00 Main Arena
Time
Content
Speaker
5Minutes
闭幕视频
Closing video
教育性TAVI病例专场-2
08:30-09:40 Branch Venue
Chairpersons: 李耿渊 吴永健
Panelists: 冯沅 何奔 王焱 徐标
Time
Content
Speaker
7Minutes
病例1
Case 1
陆毅康
Vincent LUK
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例2
Case 2
林茂新
Mao-Shin LIN
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例3
Case 3
李捷
Jie LI
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例4
Case 4
张龙岩
Long-Yan ZHANG
5Minutes
讨论：React@PCCV
Discussion React@PCCV
7Minutes
病例5
Case 5
方臻飞
Zhen-Fei FANG
5Minutes
讨论：React@PCCV
Discussion React@PCCV
10Minutes
关键信息：TAVI致胜技巧
Take home message: Tips and tricks for successful TAVI
吴永健
Yong-Jian WU